Pharmacotherapy in Autism Spectrum Disorder: How, When and Why
DOI:
https://doi.org/10.18662/brain/11.1Sup1/28Keywords:
ASD, comorbidities, pharmacotherapyAbstract
Psychiatric comorbidities are more frequent in ASD population if compared to neurotypical development peers. Several studies reported that nearly three-quarters of children and adolescents with ASD also have another psychiatric condition that contributes to worsen their clinical condition and has a negative impact on the quality of life of the entire family. The treatment of ASD symptoms and comorbidities is based on a multimodal approach of behavioural, educational and pharmacological treatments. Pharmacotherapy is employed when other therapies are unable to control the symptoms and are often useful to increase the patient’s compliance with other psychoeducational treatments. About 50% - 60% of children with ASD undergo drug therapy to reduce behaviour problems and comorbidities, and polypharmacy is common in about 30%-40%. The use of drug therapy increases with age and antipsychotics, psychostimulants and antidepressants are among the most widely used drugs. Despite the high frequency of psychotropic medication in this population, there is scarce evidence in the literature, supported by studies often limited by a low sample size, a heterogeneous population and without a control group. Large RCT on more commonly prescribed psychotropic drugs in ASD children are needed for a better evaluation of risks and benefits in ASD pediatric patients.References
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). https://doi.org/10.1176/ajp.152.8.1228
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Autism Speaks (2009, Feb 18). Autism Speaks Announces Results Reported for the Study of Fluoxetine in Autism (SOFIA), First Industry-Sponsored Trial for the AutismClinical Trials Network (ACTN). Retrieved from https://www.autismspeaks.org/news
Baio, J., Wiggins, L., ... Dowling, N. F. (2018). Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States. Surveillance Summaries, 67(6), 1–23. https://doi.org/10.15585/mmwr.ss6706a1
Baron-Cohen, S., Leslie, A. M., & Frith, U. (1985). Does the autistic child have a "theory of mind"? Cognition, 21(1), 37-46. https://doi.org/10.1016/0010-0277(85)90022-8
Bauminger, N., Solomon, M., & Rogers, S. J. (2010). Externalizing and internalizing behaviors in ASD. Autism Research, 3(3), 101-112. https://doi.org/10.1002/aur.131
Canitano, R., & Vivanti, G. (2007). Tics and Tourette syndrome in autism spectrum disorders. Autism, 11(1), 19–28. https://doi.org/10.1177/1362361307070992
Carter, A. S., Davis, N. O., Klin, A. & Volkmar, F. R. (2005). Social development in autism. In F. R. Volkmar, R. Paul, A. Klin & D. Cohen (Eds.), Handbook of autism and pervasive developmental disorders (3rd ed., vol.1, pp. 312-334). John Wiley & Sons. https://doi.org/10.1002/9780470939345.ch11
Covalciuc, S. (2020). Key issues of medical research ethics. Eastern-European Journal of Medical Humanities and Bioethics, 3(1), 11-19. http://dx.doi.org/10.18662/eejmhb.17
De Filippis, M. (2018). Depression in children and adolescents with autism spectrum disorder. Children, 5(9), 112. https://doi.org/10.3390/children5090112
Hansen, B. H., Oerbeck, B., Skirbekk, B., Petrovski, B. É., & Kristensen, H. (2018). Neurodevelopmental disorders: Prevalence and comorbidity in children referred to mental health services. Nordic Journal of Psychiatry, 72(4), 285-291. https://doi.org/10.1080/08039488.2018.1444087
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., & Iyengar, R. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30(3), 582–589. https://doi.org/10.1038/sj.npp.1300627
Joshi, G., Petty, C., Wozniak, J., Henin, A., Fried, R., Galdo, M., Kotarski, M., Walls, S., & Biederman, J. (2010). The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: A large comparative study of a psychiatrically referred population. Journal of Autism and Developmental Disorders, 40(11), 1361-1370. https://doi.org/10.1007/s10803-010-0996-9
Lai, M. C., Lombardo, M. V., & Baron-Cohen, S. (2014). Autism. The Lancet, 383(9920), 896-910. https://doi.org/10.1016/s0140-6736(13)61539-1
Lamy, M., & Erickson, C. A. (2018). Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Current Problems in Pediatric and Adolescent Health Care, 48(10), 250-264. https://doi.org/10.1016/j.cppeds.2018.08.015
Leitner, Y. (2014). The co-occurrence of autism and attention deficit hyperactivity disorder in children - What do we know? Frontiers in Human Neuroscience, 8, 268. https://doi.org/10.3389/fnhum.2014.00268
Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., Tager-Flusberg, H., & Lainhart, J. E. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7): 849–861. https://doi.org/10.1007/s10803-006-0123-0
Marcus, R.N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., & Aman, M. G. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48(11), 1110–1119. https://doi.org/10.1097/chi.0b013e3181b76658
McCracken, J. T., McGough, J., ... McMahon, D. (2002). Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine, 347(5), 314–321. https://doi.org/10.1056/nejmoa013171
Morie, K. P., Jackson, S., Zhai, Z. W., Potenza, M. N., & Dritschel, B. (2019). Mood disorders in high-functioning autism: The importance of alexithymia and emotional regulation. Journal of Autism and Developmental Disorders, 49(7), 2935-2945. https://doi.org/10.1007/s10803-019-04020-1
Nadeau, J., Sulkowski, M. L., Ung, D., Wood, J. J., Lewin, A. B., Murphy, T. K., May, J. E., & Storch, E. A. (2011). Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry, 1(6), 567–578. https://doi.org/10.2217/npy.11.62
Orinstein, A., Tyson, K. E., Suh, J., Troyb, E., Helt, M., Rosenthal, M., Barton, M. L., Eigsti, I. M., Kelley, E., Naigles, L., Schultz, R. T., Stevens, M. C., & Fein, D. A. (2015). Psychiatric symptoms in youth with a history of autism and optimal outcome. Journal of Autism and Developmental Disorders, 45(11), 3703-3714. https://doi.org/10.1007/s10803-015-2520-8
Peterson, C., Slaughter, V., Moore, C., & Wellman, H. M. (2016). Peer social skills and theory of mind in children with autism, deafness, or typical development. Developmental Psychology, 52(1), 46–57. https://doi.org/10.1037/a0039833
Research Units on Pediatric Psychopharmacology Autism Network/RUPPA. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62(11), 1266-1274. https://doi.org/10.1001/archpsyc.62.11.1266
Ring, H., Woodbury-Smith, M., Watson, P., Wheelwright, S, & Baron-Cohen, S. (2008). Clinical heterogeneity among people with high functioning autism spectrum conditions: Evidence favoring a continuous severity gradient. Behavioral and Brain Functions, 4(1), 11. https://doi.org/10.1186/1744-9081-4-11
Rossignol, D. A. (2009). Novel and emerging treatments for autism spectrum disorder: A systematic review. Ann Clin Psychiatry, 21(4), 213-236. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19917212#
Sharma, S. R., Gonda, X., & Tarazi, F. I. (2018). Autism spectrum disorder: Classification, diagnosis and therapy. Pharmacology & Therapeutics, 190, 91–104. https://doi.org/10.1016/j.pharmthera.2018.05.007
Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921–929. https://doi.org/10.1097/chi.0b013e318179964f
Tine, M., & Lucariello, J. (2012). Unique theory of mind differentiation in children with autism and Asperger syndrome. Autism Research and Treatment, 2012, 1–11. https://doi.org/10.1155/2012/505393
Van Steensel, F. J. A., Bögels, S. M., & Perrin, S. (2011). Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. Clinical Child and Family Psychology Review, 14(3), 302–317. https://doi.org/10.1007/s10567-011-0097-0
Yenkoyan, K., Grigoryan, A., Fereshetyan, K., & Yepremyan, D. (2017). Advances in understanding the pathophysiology of autism spectrum disorders. Behavioural Brain Research, 331, 92-101. https://doi.org/10.1016/j.bbr.2017.04.038
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant this journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work, with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as an earlier and greater citation of published work (See The Effect of Open Access).
BRAIN. Broad Research in Artificial Intelligence and Neuroscience Journal has an Attribution-NonCommercial-NoDerivs
CC BY-NC-ND
